Is MYO (MYO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 26.3% / 30% | 80.8% / 30% | 12.4% / 30% | 1.19% / 5% | ✗ NOT HALAL |
| DJIM | 26.3% / 33% | 80.8% / 33% | 12.4% / 33% | 1.19% / 5% | ✗ NOT HALAL |
| MSCI | 19.2% / 33% | 58.9% / 33% | 9.1% / 33% | 1.19% / 5% | ✗ NOT HALAL |
| S&P | 26.3% / 33% | 80.8% / 33% | 12.4% / 33% | 1.19% / 5% | ✗ NOT HALAL |
| FTSE | 19.2% / 33% | 58.9% / 33% | 9.1% / 50% | 1.19% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 65.7% | |
| Operating Margin | -24.4% | |
| Net Margin | -38.1% | |
| Return on Equity (ROE) | -86.2% | |
| Return on Assets (ROA) | -22.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$15M |
| Free Cash Flow | -$18M |
| Total Debt | $19M |
| Debt-to-Equity | 170.0 |
| Current Ratio | 3.3 |
| Total Assets | $39M |
Price & Trading
| Last Close | $0.68 |
| 50-Day MA | $0.79 |
| 200-Day MA | $1.18 |
| Avg Volume | 504K |
| Beta | 1.1 |
|
52-Week Range
$0.63
| |
About MYO (MYO)
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is MYO (MYO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), MYO is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is MYO's debt ratio?
MYO's debt ratio is 26.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 19.2%.
What are MYO's key financial metrics?
MYO has a market capitalization of $27M, and revenue of $41M. The company maintains a gross margin of 65.7% and a net margin of -38.1%. Return on equity stands at -86.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.